<DOC>
	<DOCNO>NCT00347685</DOCNO>
	<brief_summary>The purpose study assess safety tramadol HCl ER follow long-term treatment . The study hypothesis long-term treatment tramadol HCl ER safe effective treatment chronic , non-malignant pain .</brief_summary>
	<brief_title>A One-year , Open-label Study Assess Safety Effectiveness Extended Release Tramadol HCl Treatment Chronic , Non-malignant Pain .</brief_title>
	<detailed_description>Immediate release ( IR ) tramadol demonstrate efficacy several pain condition include : obstetrical , gynecological , orthopedic , abdominal , oral surgery . The short elimination half-life IR tramadol necessitates every 4-6 hour dose maintain optimum level analgesia chronic pain . The study medication study once-daily , extend release ( ER ) tramadol formulation . This study multicenter , multiple-dose , 1-year open-label study design ass safety effectiveness tramadol HCl ER . Patients moderate severe chronic non-malignant pain , require treatment analgesic daily basis , eligible study participation . Patients eligible enrollment follow : complete 12 week one two prior double-blind study ( `` roll-over patient '' ) without participation prior study tramadol HCl ER ( `` direct enrollment patient '' ) . Following screen evaluation baseline assessment , roll-over patient treat 38 week direct enrollment patient 58 week . At baseline ( Visit 2 ) , patient receive tramadol HCl ER 100 mg daily ( QD ) 3 day ; day 4 , increase tramadol HCl ER 200 mg QD , base tolerability . Patients require minimum dose tramadol HCl ER 200 mg QD Visit 3 . At Visit 4 , patient require begin treatment minimum dose tramadol HCl ER 300 mg QD . The maximum dose tramadol HCl ER patient &gt; = 75 year old 300 mg QD . By Visit 5 , patient &lt; 75 year old initiated tramadol HCl ER dose 400 mg QD . Patients tolerate dose increase tramadol HCl ER 300 mg 400 mg QD ( due side effect ) upon dose increase tolerate dose permit reduce tramadol HCl ER dose 300 mg QD . Patients unable tolerate tramadol HCl ER 300 mg 400 mg QD pain unresponsive appropriate dose adjustment discontinue alternate analgesic therapy initiate , appropriate .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<criteria>Patients history chronic , nonmalignant pain &gt; = 6 month require treatment analgesic ; female childbearing potential practicing abstinence medically accept form contraception negative serum pregnancy test within 7 day study entry ; patient able understand procedure , complete pain scale able communicate meaningfully study personnel ; patient agree study participation sign form indicate informed consent . Patients uncontrolled medical condition ; patient whose weight &lt; = 100 pound ; patient dysphagia difficulty swallow tablet ; patient intractable nausea vomiting ; patient history clinically significant intolerance tramadol know hypersensitivity opioid analgesic , treatment tramadol opioids contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>chronic non-malignant pain ; chronic pain ; non-malignant</keyword>
	<keyword>pain ; moderate pain ; severe pain</keyword>
</DOC>